Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-20T04:23:34.051Z Has data issue: false hasContentIssue false

P0141 - Audit of prescribing of PRN (pro re nata) medications

Published online by Cambridge University Press:  16 April 2020

H. Reddy*
Affiliation:
Marlborough House, Milton Keynes, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aim:

To ascertain the level of compliance of present documentation of PRN medication with national and local standards of good practice.

Objective:

To inform changes to current practice where room for improvement is identified.

Methodlogy:

Data collection form was designed based upon the standards found in the local prescribing policy

Audit was carried out on all inpatients on Chafron and Marlborough House

3 month time period August to October 2006

The medication records of 19 patients were viewed

All PRN medication was included in the audit.

Results against standards:

Not more than 1 medicine from any BNF therapeutic category should be prescribed as a PRN at any one time: 2 patients did not meet this standard

100% Compliance to standards

The following 7 standards achieved 100% compliance:

Legible prescription

Written in black ink

Dose recorded

Method recorded

Signature recorded

Start date recorded

Time given recorded, where applicable.

Reccomendations

Increased prescribing practice training for medical staff (doctors). This is covered by pharmacist staff at induction.

Re-audit in 6 months.

Type
Poster Session III: Forensic Psychiatry
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.